论文部分内容阅读
目的:探讨功能性消化不良的临床不同药物治疗方法与效果。方法:70例功能性消化不良患者根据入院顺序平分为两组即治疗组与对照组各35例,对照组服用多潘立酮胶囊治疗,治疗组服用莫沙必利分散片治疗。结果:经过治疗后,治疗组总有效率为97.1%,对照组总有效率为80.0%,差异有统计学意义(P<0.05)。两组均未出现明显的不良反应,血、尿、心电图、肝、肾功能均无明显异常。两组不良反应情况对比无差异。结论:多潘立酮与莫沙必利治疗功能性消化不良都能取得比较好的安全效果,但是莫沙必利治疗能更有效的提高治疗效果,值得推广应用。
Objective: To explore the functional dyspepsia clinical different drug treatment methods and effects. Methods: Seventy patients with functional dyspepsia were equally divided into two groups according to admission sequence: 35 cases in the treatment group and the control group, and the domperidone capsule in the control group. Mosapride dispersible tablets were used in the treatment group. Results: After treatment, the total effective rate was 97.1% in the treatment group and 80.0% in the control group, the difference was statistically significant (P <0.05). No obvious adverse reaction was found in both groups, blood, urine, electrocardiogram, liver and kidney function were no abnormalities. There was no difference in adverse reactions between the two groups. Conclusion: Both domperidone and mosapride have good safety effect in treating functional dyspepsia. However, mosapride can improve the therapeutic effect more effectively and is worth popularizing and applying.